Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_assertion type Assertion NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_head.
- NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_assertion description "[CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addition of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_provenance.
- NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_assertion evidence source_evidence_literature NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_provenance.
- NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_assertion SIO_000772 15256482 NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_provenance.
- NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_assertion wasDerivedFrom befree-20140225 NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_provenance.
- NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_assertion wasGeneratedBy ECO_0000203 NP477840.RAcxxQJx8fIxG8U9jpX14IHes4c8OmWRscvpvd6X0Vl1w130_provenance.